Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Brain Diseases Clinical Trials

7 recruiting trials for Brain Diseases. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
7
Total Trials
7
Recruiting Now
1
Phase 3 Trials
6
Sponsors

Recruiting Trials

RECRUITINGNCT05065450

Amygdala Memory Enhancement

The objective is to understand how amygdala activation affects other medial temporal lobe structures to prioritize long-term memories. The project is relevant to disorders of...

Sponsor: Washington University School of MedicineEnrolling: 901 location
RECRUITINGNCT06121336

PRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke

The investigators recently identified Brain-derived tau (BD-tau) as a sensitive blood-based biomarker for brain injury in acute ischemic stroke: in patients with acute ischemic...

Sponsor: Ludwig-Maximilians - University of MunichEnrolling: 1001 location
RECRUITINGNCT06876857

University of Central Florida CereBank

Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain...

Sponsor: University of Central FloridaEnrolling: 500001 location
RECRUITINGNCT06954610

Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation

Background Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting up to 10% of the elderly. Ischemic stroke is the main complication of AF and cardioembolism...

Sponsor: Insel Gruppe AG, University Hospital BernEnrolling: 5001 location
RECRUITINGNCT04406818

Metabolic and Hemodynamic Reserve in Pediatric SCA

The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life. SCA participants and...

Sponsor: Washington University School of MedicineEnrolling: 1201 location
RECRUITINGNCT06337864

Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria

The overall aim of this study is to evaluate LNAA treatment as a potential alternative to conventional dietary treatment for PKU. This study investigates the effects of LNAA...

Sponsor: Rigshospitalet, DenmarkEnrolling: 302 locations
RECRUITINGPhase 3NCT05508789

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The study duration including screening and follow-up is...

Sponsor: Eli Lilly and CompanyEnrolling: 150020 locations